-transparent.png){kind=logo}
We have investigated the prevalence of gastrointestinal (GI) symptoms in 98 individuals with Parkinson's disease (PD) and in a control group of 50. Seventy-nine of those with PD were being treated with dopaminergic medications and 19 were untreated. Those symptoms occurring more frequently in PD patients than in controls included abnormal salivation, dysphagia, nausea, constipation, and defecatory dysfunction. Except for defecatory dysfunction, symptoms did not correlate with treatment but instead correlated with disease severity. This suggests that the GI symptoms of PD reflect direct involvement in the GI tract by the primary disease process.
Related Publications
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
January 2025,
Journal of central nervous system disease,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
February 2012,
Expert review of neurotherapeutics,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
September 2015,
Revista de neurologia,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
January 2016,
Parkinson's disease,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
June 2022,
Movement disorders : official journal of the Movement Disorder Society,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
January 2019,
Annals of Indian Academy of Neurology,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
May 2013,
Journal of neurology,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
January 2021,
Clinical parkinsonism & related disorders,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
February 2003,
The Lancet. Neurology,
L L Edwards, and
R F Pfeiffer, and
E M Quigley, and
R Hofman, and
M Balluff
January 1998,
Clinical neuroscience (New York, N.Y.),
